drugset
drugset / Trial / NCT01329744

Effects of IGF-I in HIV Metabolic Disease

NCT01329744 ↗

Phase 1 Terminated 16 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study examines the effects of recombinant insulin like growth factor - I on body composition, glucose homeostasis, and lipids, in adults with HIV infection and signs of metabolic disease.

Timeline

Start
2011-06
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject mecasermin Protein / enzyme biologic — Subcutaneous

Indications

lipodystrophy